These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19543958)

  • 1. Specific immunotherapy to birch allergen does not enhance suppression of Th2 cells by CD4(+)CD25(+) regulatory T cells during pollen season.
    Grindebacke H; Larsson P; Wing K; Rak S; Rudin A
    J Clin Immunol; 2009 Nov; 29(6):752-60. PubMed ID: 19543958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune regulation by CD4+CD25+ T cells and interleukin-10 in birch pollen-allergic patients and non-allergic controls.
    Thunberg S; Akdis M; Akdis CA; Grönneberg R; Malmström V; Trollmo C; van Hage M; Gafvelin G
    Clin Exp Allergy; 2007 Aug; 37(8):1127-36. PubMed ID: 17651141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season.
    Grindebacke H; Wing K; Andersson AC; Suri-Payer E; Rak S; Rudin A
    Clin Exp Allergy; 2004 Sep; 34(9):1364-72. PubMed ID: 15347368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
    Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
    J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
    Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C
    J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
    Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
    J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of birch pollen allergen Bet v 1-specific regulatory T cells.
    Nagato T; Kobayashi H; Yanai M; Sato K; Aoki N; Oikawa K; Kimura S; Abe Y; Celis E; Harabuchi Y; Tateno M
    J Immunol; 2007 Jan; 178(2):1189-98. PubMed ID: 17202384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte antigen-G and regulatory T cells during specific immunotherapy for pollen allergy.
    Sørensen AE; Johnsen CR; Dalgaard LT; Würtzen PA; Kristensen B; Larsen MH; Ullum H; Søes-Petersen U; Hviid TV
    Int Arch Allergy Immunol; 2013; 162(3):237-52. PubMed ID: 24022071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.
    Wang LH; Lin YH; Yang J; Guo W
    Int Arch Allergy Immunol; 2009; 148(3):199-210. PubMed ID: 18849611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of CD4(+) CD25(+) Foxp3(+) and IL-10-secreting type I T regulatory cells to cluster-specific immunotherapy for allergic rhinitis in children.
    Lou W; Wang C; Wang Y; Han D; Zhang L
    Pediatr Allergy Immunol; 2012 Mar; 23(2):140-9. PubMed ID: 22192331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of CD154+ T cells following ex vivo birch allergen stimulation defines a close relationship between T cell subsets in healthy volunteers.
    Smith KA; Gray NJ; Cheek E; Saleh F; Lavender J; Frew AJ; Kern F; Tarzi MD
    BMC Immunol; 2013 Mar; 14():14. PubMed ID: 23521868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasonal changes in suppressive capacity of CD4+ CD25+ T cells from patients with hayfever are allergen-specific and may result in part from expansion of effector T cells among the CD25+ population.
    Anderson AE; Mackerness KJ; Aizen M; Carr VA; Nguyen D; Du Pre F; Durham SR; Robinson DS
    Clin Exp Allergy; 2009 Nov; 39(11):1693-9. PubMed ID: 19622090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of CD4+CD25+CD127lo regulatory T cells does not increase allergen-driven T cell activation.
    Skrindo I; Farkas L; Kvale EO; Johansen FE; Jahnsen FL
    Clin Exp Allergy; 2008 Nov; 38(11):1752-9. PubMed ID: 18681851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine production by peripheral blood mononuclear cells following birch-pollen immunotherapy.
    Movérare R; Elfman L; Björnsson E; Stålenheim G
    Immunol Lett; 2000 Jul; 73(1):51-6. PubMed ID: 10963811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory activity of human CD4 CD25 T cells depends on allergen concentration, type of allergen and atopy status of the donor.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Immunology; 2005 Sep; 116(1):103-11. PubMed ID: 16108822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen provocation increases TH2-cytokines and FOXP3 expression in the asthmatic lung.
    Thunberg S; Gafvelin G; Nord M; Grönneberg R; Grunewald J; Eklund A; van Hage M
    Allergy; 2010 Mar; 65(3):311-8. PubMed ID: 19845574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4(+)CD25(+)Foxp3(+) T cells, are decreased in peripheral blood of patients with persistent allergic rhinitis.
    Han D; Wang C; Lou W; Gu Y; Wang Y; Zhang L
    Clin Immunol; 2010 Aug; 136(2):292-301. PubMed ID: 20403730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
    Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
    J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and immunological correlates of pre-co-seasonal sublingual immunotherapy with birch monomeric allergoid in patients with allergic rhinoconjunctivitis.
    Burastero SE; Mistrello G; Paolucci C; Breda D; Roncarolo D; Zanotta S; Falagiani P
    Int J Immunopathol Pharmacol; 2009; 22(2):343-52. PubMed ID: 19505388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.